January 27, 2026 a 07:43 am
DGX: Fundamental Ratio Analysis - Quest Diagnostics Incorporated
Quest Diagnostics Incorporated operates within the healthcare sector, providing essential diagnostic services worldwide. The company's stock (DGX) shows a stable fundamental rating, displaying resilience amid market fluctuations. Investors may find it attractive due to its consistent service delivery and strong market position.
Fundamental Rating
The fundamental assessment suggests Quest Diagnostics holds steady across key metrics, reflecting its stable market presence.
| Category | Score | Visualization |
|---|---|---|
| Discounted Cash Flow | 4 | |
| Return on Equity | 4 | |
| Return on Assets | 4 | |
| Debt to Equity | 1 | |
| Price to Earnings | 2 | |
| Price to Book | 2 |
Historical Rating
Review of historical ratings shows consistency in Quest Diagnostics' performance metrics over time.
| Date | Overall Score | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2026-01-26 | 3 | 4 | 4 | 4 | 1 | 2 | 2 |
| Prior | 0 | 4 | 4 | 4 | 1 | 2 | 2 |
Analyst Price Targets
Analysts present optimistic price targets with a consensus on potential stock performance.
| High | Low | Median | Consensus |
|---|---|---|---|
| $215 | $190 | $202.5 | $201.6 |
Responsive stock price chart indicating trends and projections.
Analyst Sentiment
Analyst recommendations lean towards holding the stock, given its stable performance outlook.
| Recommendation | Count | Distribution |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 12 | |
| Hold | 19 | |
| Sell | 3 | |
| Strong Sell | 0 |
Conclusion
Quest Diagnostics Incorporated remains a strong entity within the healthcare diagnostics market. The company's consistent performance in core areas such as ROE and ROA, coupled with a reasonable debt-to-equity ratio, positions it well against peers. While the debt levels indicate some financial leverage, the fundamental and historical scores remain robust. However, potential investors should consider the ‘Hold’ consensus from analysts, reflecting a balanced perspective on future stock returns. The stock's price targets indicate potential growth, especially evident in the median and high projections.